SLC5A2 and Schnyder corneal dystrophy: Although a recent meta‐analysis revealed similar cardiorenal benefits of SGLT‐2 inhibition in both males and females,44 we cannot exclude a sex‐specific effect of SGLT‐2 inhibition in SCD.